Shanghai Haixin Group Co Ltd A (600851) - Total Liabilities
Based on the latest financial reports, Shanghai Haixin Group Co Ltd A (600851) has total liabilities worth CN¥813.34 Million CNY (≈ $119.02 Million USD) as of March 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
Shanghai Haixin Group Co Ltd A - Total Liabilities Trend (1993–2025)
This chart illustrates how Shanghai Haixin Group Co Ltd A's total liabilities have evolved over time, based on quarterly financial data. See working capital position of Shanghai Haixin Group Co Ltd A to evaluate short-term liquidity relative to the company's equity base.
Shanghai Haixin Group Co Ltd A Competitors by Total Liabilities
The table below lists competitors of Shanghai Haixin Group Co Ltd A ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Taihe Technologies
SHE:300801
|
China | CN¥546.18 Million |
|
Sunrise Group Co Ltd
SHE:002752
|
China | CN¥4.15 Billion |
|
Shenzhen Centralcon Investment Holding Co Ltd
SHE:000042
|
China | CN¥31.91 Billion |
|
Seegene Inc
KQ:096530
|
Korea | ₩214.46 Billion |
|
Youcare Pharmaceutical Group Co. Ltd. A
SHG:688658
|
China | CN¥1.91 Billion |
|
ARS Pharmaceuticals, Inc
NASDAQ:SPRY
|
USA | $213.39 Million |
|
Gansu Yatai Industrial Development Co Ltd
SHE:000691
|
China | CN¥548.96 Million |
|
Cangzhou Dahua Co Ltd
SHG:600230
|
China | CN¥1.68 Billion |
Liability Composition Analysis (1993–2025)
This chart breaks down Shanghai Haixin Group Co Ltd A's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see 600851 stock market capitalisation.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 5.61 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.18 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.15 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Shanghai Haixin Group Co Ltd A's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Shanghai Haixin Group Co Ltd A (1993–2025)
The table below shows the annual total liabilities of Shanghai Haixin Group Co Ltd A from 1993 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-12-31 | CN¥925.47 Million ≈ $135.42 Million |
+11.44% |
| 2024-12-31 | CN¥830.43 Million ≈ $121.52 Million |
+7.11% |
| 2023-12-31 | CN¥775.29 Million ≈ $113.45 Million |
-14.92% |
| 2022-12-31 | CN¥911.22 Million ≈ $133.34 Million |
-12.62% |
| 2021-12-31 | CN¥1.04 Billion ≈ $152.60 Million |
-16.28% |
| 2020-12-31 | CN¥1.25 Billion ≈ $182.27 Million |
+12.21% |
| 2019-12-31 | CN¥1.11 Billion ≈ $162.43 Million |
+25.54% |
| 2018-12-31 | CN¥884.20 Million ≈ $129.39 Million |
-6.16% |
| 2017-12-31 | CN¥942.20 Million ≈ $137.87 Million |
-13.48% |
| 2016-12-31 | CN¥1.09 Billion ≈ $159.35 Million |
-12.26% |
| 2015-12-31 | CN¥1.24 Billion ≈ $181.63 Million |
-28.07% |
| 2014-12-31 | CN¥1.73 Billion ≈ $252.51 Million |
+47.10% |
| 2013-12-31 | CN¥1.17 Billion ≈ $171.66 Million |
-5.17% |
| 2012-12-31 | CN¥1.24 Billion ≈ $181.01 Million |
+2.16% |
| 2011-12-31 | CN¥1.21 Billion ≈ $177.19 Million |
-14.14% |
| 2010-12-31 | CN¥1.41 Billion ≈ $206.38 Million |
-26.21% |
| 2009-12-31 | CN¥1.91 Billion ≈ $279.68 Million |
+36.56% |
| 2008-12-31 | CN¥1.40 Billion ≈ $204.80 Million |
-48.11% |
| 2007-12-31 | CN¥2.70 Billion ≈ $394.68 Million |
+74.13% |
| 2006-12-31 | CN¥1.55 Billion ≈ $226.66 Million |
+10.64% |
| 2005-12-31 | CN¥1.40 Billion ≈ $204.86 Million |
+1.26% |
| 2004-12-31 | CN¥1.38 Billion ≈ $202.31 Million |
+12.87% |
| 2003-12-31 | CN¥1.22 Billion ≈ $179.25 Million |
+2.41% |
| 2002-12-31 | CN¥1.20 Billion ≈ $175.03 Million |
+12.73% |
| 2001-12-31 | CN¥1.06 Billion ≈ $155.26 Million |
+29.32% |
| 2000-12-31 | CN¥820.47 Million ≈ $120.06 Million |
+5.06% |
| 1999-12-31 | CN¥780.95 Million ≈ $114.28 Million |
+24.11% |
| 1998-12-31 | CN¥629.22 Million ≈ $92.07 Million |
+0.26% |
| 1997-12-31 | CN¥627.58 Million ≈ $91.83 Million |
+39.52% |
| 1996-12-31 | CN¥449.83 Million ≈ $65.82 Million |
+106.86% |
| 1995-12-31 | CN¥217.45 Million ≈ $31.82 Million |
+129.06% |
| 1994-12-31 | CN¥94.93 Million ≈ $13.89 Million |
+24.04% |
| 1993-12-31 | CN¥76.53 Million ≈ $11.20 Million |
-- |
About Shanghai Haixin Group Co Ltd A
Shanghai Haixin Group Co., Ltd. engages in the manufacture and sale of pharmaceutical products in China and internationally. It is also involved in leasing of park properties, financial investment and commodity trading, as well as production and sales of chemical drugs through its sales platform or local distributors; and research and development, production, and sales of plush fabrics and clothi… Read more